0913693 B.C. Ltd. REPCF
Set alert
0.00 USD 0.00 0.00%
At close · Oct 29
0.042835 Day range 0.042835
0.00001 52-week range 0.0001
- YTD
- 0.00%
- 1 year
- 0.00%
- Open
- 0.042835
- Prev close
- 0.0001
- Mkt cap
- 7.36K
- Vol
- 550
- Avg vol
- 929
- EPS
- 0.00
- P/E
- 0.00
More statistics
- Low
- 0.042835
- High
- 0.042835
2Y chart
Signals (15)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Jun 24, 2026 | 4 months ago |
| MACD: Sell Signal | May 7, 2026 | 5 months ago |
| MACD: Buy Signal | Apr 8, 2026 | 6 months ago |
| SMA: Bullish | Apr 6, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 1, 2026 | 7 months ago |
| MACD: Buy Signal | Sep 26, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 8, 2025 | 1 year ago |
| RSI: Oversold | Sep 8, 2025 | 1 year ago |
| SMA: Bullish | Apr 1, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 14, 2025 | 1 year ago |
| SMA: Bearish | Jan 21, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 21, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 3, 2025 | 1 year ago |
| RSI: Overbought | Jan 3, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 2, 2025 | 1 year ago |
News
- RepliCel Files Notice of Arbitration against Shiseido Company to Resolve its License Agreement Dispute Regarding its Androgenetic Alopecia Cell Therapy
- RepliCel Life Sciences Appoints One of Japan's Foremost Regenerative Medicine Industry Business Leaders as Strategic Advisor
- RepliCel and University of Victoria Collaboration Leads to Bioengineering Innovations, Funding, and Patents
- RepliCel Applies for Manufacturing Approval for Its Collagen and Tissue Regeneration Cell Therapies
- RepliCel Adds Independent Director
- RepliCel Launches Preparations for Second Skin Rejuvenation and Tendon Regeneration Clinical Studies
- RepliCel Announces Record Year in Patents Granted
- RepliCel Announces Appointment of Leading Sports Medicine Expert as Orthopedics Clinical Advisor (Japan)
- RepliCel Closes Second Tranche of Strategic Investment Commitment
- RepliCel Announces a Binding Term Sheet For Strategic Investment and U.S. Partnership
Your note
Sign in to keep a note on REPCF — it syncs with the Stock Master app.